Related Experiment Video
Updated: Jul 28, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Management of Pyogenic Liver Abscesses: Contemporary Strategies and Challenges.
John C Lam1, William Stokes2,3,4
1Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA.
Pyogenic liver abscesses (PLAs) are serious hepatic infections. Effective management requires prompt source control and tailored antimicrobial therapy based on pathogen and clinical factors.
Area of Science:
- Hepatology
- Infectious Diseases
- Microbiology
Background:
- Pyogenic liver abscesses (PLAs) represent a significant cause of morbidity and mortality.
- Understanding PLA pathogenesis is crucial for effective treatment strategies.
- Diverse etiologies and challenging microorganisms complicate PLA management.
Purpose of the Study:
- To review the mechanisms, pathogenesis, and management of pyogenic liver abscesses.
- To highlight the role of specific pathogens like Streptococcus anginosus group and hypervirulent Klebsiella pneumoniae.
- To emphasize the critical importance of source control and individualized antimicrobial therapy.
Main Methods:
- Review of existing literature on pyogenic liver abscesses.
- Analysis of PLA pathogenesis based on host factors, clinical presentation, and causative microorganisms.
- Discussion of diagnostic imaging and interventional strategies for source control.
Main Results:
- PLAs can arise from various routes including portal vein, biliary tract, hepatic artery, trauma, contiguous spread, or cryptogenically.
- Emerging pathogens such as Streptococcus anginosus group, hypervirulent Klebsiella pneumoniae, and multidrug-resistant gram-negative bacteria pose treatment challenges.
- Abdominal imaging is essential for characterization and guiding source control.
Conclusions:
- Source control is paramount in PLA management, followed by appropriate antimicrobial therapy.
- Empirical antibiotic choices should be guided by suspected etiology.
- Treatment duration is individualized, considering source control success, host factors, and clinical response.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Acute Pancreatitis II: Clinical Manifestations and Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acute Pyelonephritis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:

